Latest Ally Bridge Group (NY) LLC Stock Portfolio
$167Million
Equity Portfolio Value
Last Reported on: 14 Feb, 2024
About Ally Bridge Group (NY) LLC and it’s 13F Hedge Fund Stock Holdings
Ally Bridge Group (NY) LLC is a hedge fund based in NEW YORK, NY. On 31-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $146.7 Millions. In it's latest 13F Holdings report, Ally Bridge Group (NY) LLC reported an equity portfolio of $167.8 Millions as of 31 Dec, 2023.
The top stock holdings of Ally Bridge Group (NY) LLC are JSPR, ARGX, SLNO. The fund has invested 17.2% of it's portfolio in JASPER THERAPEUTICS INC and 7.9% of portfolio in ARGENX SE - ADR.
The fund managers got completely rid off CYTOKINETICS INC (CYTK), ARDELYX INC (ARDX) and AMBRX BIOPHARMA INC (AMAM) stocks. They significantly reduced their stock positions in MOONLAKE IMMUNOTHERAPEUTICS (MLTX), INTRA-CELLULAR THERAPIES INC (ITCI) and APELLIS PHARMACEUTICALS INC (APLS). Ally Bridge Group (NY) LLC opened new stock positions in ARGENX SE - ADR (ARGX), SOLENO THERAPEUTICS INC (SLNO) and CYMABAY THERAPEUTICS INC (CBAY). The fund showed a lot of confidence in some stocks as they added substantially to PROMIS NEUROSCIENCES INC (PMN), GERON CORP (GERN) and MERUS NV (MRUS).
The top stock holdings of Ally Bridge Group (NY) LLC are JSPR, ARGX, SLNO. The fund has invested 17.2% of it's portfolio in JASPER THERAPEUTICS INC and 7.9% of portfolio in ARGENX SE - ADR.
The fund managers got completely rid off CYTOKINETICS INC (CYTK), ARDELYX INC (ARDX) and AMBRX BIOPHARMA INC (AMAM) stocks. They significantly reduced their stock positions in MOONLAKE IMMUNOTHERAPEUTICS (MLTX), INTRA-CELLULAR THERAPIES INC (ITCI) and APELLIS PHARMACEUTICALS INC (APLS). Ally Bridge Group (NY) LLC opened new stock positions in ARGENX SE - ADR (ARGX), SOLENO THERAPEUTICS INC (SLNO) and CYMABAY THERAPEUTICS INC (CBAY). The fund showed a lot of confidence in some stocks as they added substantially to PROMIS NEUROSCIENCES INC (PMN), GERON CORP (GERN) and MERUS NV (MRUS).
New Buys
| Ticker | $ Bought |
|---|---|
| ARGENX SE - ADR | 13,315,000 |
| SOLENO THERAPEUTICS INC | 12,475,500 |
| CYMABAY THERAPEUTICS INC | 11,572,300 |
| OLEMA PHARMACEUTICALS INC | 9,246,260 |
| ALPINE IMMUNE SCIENCES INC | 6,809,580 |
| AMBRX BIOPHARMA INC | 5,487,850 |
| AVADEL PHARMACEUTICALS-ADR | 4,900,150 |
| HARPOON THERAPEUTICS INC | 4,870,910 |
New stocks bought by Ally Bridge Group (NY) LLC
Additions
| Ticker | % Inc. |
|---|---|
| PROMIS NEUROSCIENCES INC | 100 |
| GERON CORP | 33.76 |
| MERUS NV | 24.18 |
| JASPER THERAPEUTICS INC | 16.38 |
| AMYLYX PHARMACEUTICALS INC | 1.13 |
Additions to existing portfolio by Ally Bridge Group (NY) LLC
Reductions
| Ticker | % Reduced |
|---|---|
| MOONLAKE IMMUNOTHERAPEUTICS | -21.64 |
| INTRA-CELLULAR THERAPIES INC | -19.23 |
| APELLIS PHARMACEUTICALS INC | -17.49 |
| XENON PHARMACEUTICALS INC | -9.36 |
| AXSOME THERAPEUTICS INC | -8.8 |
| COMPASS THERAPEUTICS INC | -8.75 |
Ally Bridge Group (NY) LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| PRAXIS PRECISION MEDICINES I | -1,806,390 |
| ARDELYX INC | -3,595,930 |
| BLACK DIAMOND THERAPEUTICS I | -1,820,130 |
| AMBRX BIOPHARMA INC | -3,232,520 |
| CYTOKINETICS INC | -6,580,830 |
| MIRATI THERAPEUTICS INC | -3,061,530 |
Ally Bridge Group (NY) LLC got rid off the above stocks
Current Stock Holdings of Ally Bridge Group (NY) LLC
Last Reported on: 14 Feb, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| ALPN | ALPINE IMMUNE SCIENCES INC | 4.06 | 357,271 | 6,809,580 | NEW | ||
| AMAM | AMBRX BIOPHARMA INC | 3.27 | 385,383 | 5,487,850 | NEW | ||
| AMAM | AMBRX BIOPHARMA INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| AMLX | AMYLYX PHARMACEUTICALS INC | 2.42 | 275,773 | 4,059,380 | ADDED | 1.13 | |
| APLS | APELLIS PHARMACEUTICALS INC | 5.35 | 150,000 | 8,979,000 | REDUCED | -17.49 | |
| ARDX | ARDELYX INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| ARGX | ARGENX SE - ADR | 7.93 | 35,000 | 13,315,000 | NEW | ||
| AVDL | AVADEL PHARMACEUTICALS-ADR | 2.92 | 347,036 | 4,900,150 | NEW | ||
| AXSM | AXSOME THERAPEUTICS INC | 4.78 | 100,862 | 8,027,610 | REDUCED | -8.8 | |
| BDTX | BLACK DIAMOND THERAPEUTICS I | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| CBAY | CYMABAY THERAPEUTICS INC | 6.89 | 489,938 | 11,572,300 | NEW | ||
| CMPX | COMPASS THERAPEUTICS INC | 0.78 | 834,630 | 1,302,020 | REDUCED | -8.75 | |
| CNTX | CONTEXT THERAPEUTICS INC | 0.49 | 725,951 | 820,325 | UNCHANGED | 0.00 | |
| CYTK | CYTOKINETICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| GERN | GERON CORP | 3.74 | 2,971,640 | 6,270,160 | ADDED | 33.76 | |
| HARP | HARPOON THERAPEUTICS INC | 2.90 | 428,400 | 4,870,910 | NEW | ||
| ITCI | INTRA-CELLULAR THERAPIES INC | 6.03 | 141,348 | 10,123,300 | REDUCED | -19.23 | |
| JSPR | JASPER THERAPEUTICS INC | 17.20 | 3,659,260 | 28,871,500 | ADDED | 16.38 | |
| MDVL | MEDAVAIL HOLDINGS INC | 0.32 | 117,897 | 529,358 | UNCHANGED | 0.00 | |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 5.16 | 143,479 | 8,664,700 | REDUCED | -21.64 | |
| MRTX | MIRATI THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| MRUS | MERUS NV | 4.50 | 274,923 | 7,560,380 | ADDED | 24.18 | |
| OLMA | OLEMA PHARMACEUTICALS INC | 5.51 | 659,035 | 9,246,260 | NEW | ||
| PMN | PROMIS NEUROSCIENCES INC | 0.73 | 1,066,670 | 1,226,680 | ADDED | 100 | |
| PRAX | PRAXIS PRECISION MEDICINES I | 0.94 | 70,424 | 1,569,050 | NEW | ||
| PRAX | PRAXIS PRECISION MEDICINES I | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| SLNO | SOLENO THERAPEUTICS INC | 7.43 | 309,950 | 12,475,500 | NEW | ||
| XENE | XENON PHARMACEUTICALS INC | 6.64 | 241,961 | 11,144,700 | REDUCED | -9.36 |